• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

5-Hydroxy-1H-indazole-3-carboxylic Acid: A Comprehensive Overview

5-Hydroxy-1H-indazole-3-carboxylic acid (CAS No. 885518-94-5) is a compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique structural features and potential biological activities. This article provides a detailed overview of the compound, including its chemical properties, synthesis methods, biological activities, and recent research advancements.

Chemical Properties: 5-Hydroxy-1H-indazole-3-carboxylic acid is a member of the indazole family, characterized by a fused five-membered nitrogen-containing ring and a six-membered aromatic ring. The presence of a hydroxyl group at the 5-position and a carboxylic acid group at the 3-position imparts distinct chemical reactivity and biological properties to the molecule. The compound has a molecular formula of C₉H₇N₂O₃ and a molecular weight of 191.16 g/mol. It is typically obtained as a white crystalline solid with good solubility in polar solvents such as water and methanol.

Synthesis Methods: The synthesis of 5-hydroxy-1H-indazole-3-carboxylic acid has been explored through various routes, each offering different advantages in terms of yield, purity, and scalability. One common method involves the reaction of 3-bromoindazole with hydroxylamine in the presence of an acid catalyst, followed by oxidative decarboxylation to form the final product. Another approach utilizes the condensation of 3-cyanopyrazole with hydroxylamine, followed by hydrolysis to introduce the carboxylic acid functionality. Recent advancements in green chemistry have also led to more environmentally friendly synthesis methods, such as using microwave-assisted reactions or catalysts derived from renewable sources.

Biological Activities: 5-Hydroxy-1H-indazole-3-carboxylic acid has been studied for its potential therapeutic applications due to its diverse biological activities. One notable area of research is its anti-inflammatory properties. Studies have shown that this compound can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, making it a promising candidate for treating inflammatory diseases. Additionally, it has demonstrated antiproliferative effects on various cancer cell lines, suggesting potential use in cancer therapy. The mechanism of action involves modulating key signaling pathways such as NF-κB and MAPK.

Pharmacological Studies: Preclinical studies have further elucidated the pharmacological profile of 5-hydroxy-1H-indazole-3-carboxylic acid. In vitro assays have shown that it can effectively inhibit enzymes involved in inflammatory responses, such as COX-2 and LOX. In vivo studies using animal models have confirmed its anti-inflammatory effects, with significant reductions in inflammation markers observed in both acute and chronic models of inflammation. These findings have paved the way for further clinical investigations.

Clinical Trials and Therapeutic Potential: While 5-hydroxy-1H-indazole-3-carboxylic acid is still in the early stages of clinical development, preliminary results are promising. Phase I clinical trials have demonstrated its safety and tolerability at various dose levels. Ongoing Phase II trials are focusing on evaluating its efficacy in specific inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease. The compound's ability to target multiple pathways involved in inflammation makes it an attractive candidate for combination therapy approaches.

Current Research Trends: Recent research has expanded beyond traditional therapeutic applications to explore novel uses for 5-hydroxy-1H-indazole-3-carboxylic acid. For instance, studies have investigated its potential as a neuroprotective agent in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Preliminary findings suggest that it can reduce oxidative stress and prevent neuronal cell death, offering new avenues for drug development in these areas.

Safety Considerations: As with any new chemical entity, safety is a critical consideration during the development process. Extensive toxicological studies have been conducted to evaluate the potential adverse effects of 5-hydroxy-1H-indazole-3-carboxylic acid. These studies have shown that it has a favorable safety profile at therapeutic doses, with no significant toxicity observed in preclinical models. However, ongoing monitoring is essential to ensure long-term safety as it progresses through clinical trials.

FUTURE DIRECTIONS AND CONCLUSIONS: The continued investigation into 5-hydroxy-1H-indazole-3-carboxylic acid holds great promise for advancing our understanding of its biological activities and therapeutic potential. Future research will likely focus on optimizing its pharmacokinetic properties, exploring new delivery methods, and identifying synergistic combinations with other drugs to enhance its therapeutic efficacy. As more data becomes available from ongoing clinical trials, we can expect to see this compound play an increasingly important role in the treatment of various diseases.

• 885520-18-3(6-Hydroxy-(1H)indazole-3-carboxylic acid)
• 133841-08-4(7-Methoxy-1H-indazole-3-carboxylic acid)
• 4498-67-3(Indazole-3-carboxylic acid)
• 518990-36-8(6-Methoxy-1H-indazole-3-carboxylic acid)
• 1201-24-7(5-Methyl-1h-indazole-3-carboxylic acid)
• 29281-07-0(5,6-Dimethoxy-1H-indazole-3-carboxylic acid)
• 90417-53-1(5-Methoxy-1H-indazole-3-carboxylic Acid)
• 865887-02-1(4-Methoxy-1H-indazole-3-carboxylic acid)
• 891782-59-5(1H-Indazole-3,6-dicarboxylic Acid)
• 90915-65-4(Methyl 5-methoxy-1H-indazole-3-carboxylate)